Showing 1110 – 1120 of 1303 results
-
TransMedics Group Inc Initiation
William Blair initiated research coverage of TransMedics Group, Inc. (TMDX $94.04), the leading provider of organ care systems for end-stage organ failure patients across multiple disease states.
-
Arcturus Therapeutics Holdings Inc Initiation
William Blair initiated research coverage of Arcturus Therapeutics Holdings Inc. (ARCT $35.50), a company focused on creating mRNA vaccines and therapies using its proprietary LUNAR mRNA- LNP technologies.
-
The Procter and Gamble Company Initiation
William Blair initiated research coverage of The Procter & Gamble Company (PG $153.59), a global leader in the consumer packaged goods industry.
-
Avid Bioservices Inc Initiation
William Blair initiated research coverage of Avid Bioservices, Inc. (CDMO $10.01), a contract development and manufacturing organization (CDMO) focused on biologics drug substance manufacturing.
-
The Trade Desk Inc Initiation
William Blair initiated research coverage of The Trade Desk, Inc. (TTD $79.93), a company providing programmatic marketing automation technologies, services, and products.
-
CymaBay Therapeutics Inc Initiation
William Blair initiated research coverage of CymaBay Therapeutics, Inc. (CBAY $8.66), a clinical-stage biotechnology company that is developing therapeutics for liver and other chronic diseases.
-
Paycor HCM Inc Initiation
William Blair initiated research coverage of Paycor HCM, Inc. (PYCR $26.52), a cloud human capital management (HCM) provider that targets businesses with 10 to 1,000 employees.
-
Costco Wholesale Corporation Initiation
William Blair initiated research coverage of Costco Wholesale Corporation (COST $498.65), a big-box retailer offering its membership base exclusive access to discounted prices across groceries, fresh food, general merchandise, services, and gasoline.
-
Autodesk Inc Initiation
William Blair initiated research coverage of Autodesk, Inc. (ADSK $196.31), a leading enterprise software provider of design, planning, and execution tools for the manufacturing; architecture, engineering, and construction (AEC); and media and entertainment end-markets.
-
Hansa Biopharma AB Initiation
William Blair initiated research coverage of Hansa Biopharma AB (HNSA SEK 47.06), a biotechnology company focused on the development of the immunoglobin G (IgG)-cleaving enzyme imlifidase for serious diseases driven by IgG antibodies.